Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Claustrophobia

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Claustrophobia in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krupina, NA1
Orlova, IN1
Khlebnikova, NN1
Grafova, VN1
Smirnova, VS1
Kukushkin, ML1
Kryzhanovskii, GN1
Pankova, NB1
Rodina, VI1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Claustrophobia

ArticleYear
Experimental depressive-pain syndrome in rats with initial various anxiety-phobic levels: a behavioral study.
    Bulletin of experimental biology and medicine, 2002, Volume: 133, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anxiety; Denervation; Depressive Disorder; Do

2002